Sort
23,748 grants matching “melanoma”
Novel Therapeutics Targeting INPP5A Pathway in Squamous Cell Carcinoma
$346,236Aleksandar None Sekulic · Mayo Clinic Arizona · R01 · FY2018 · CA
T4 Endonuclease V Structure-Function Analysis
$346,233R Stephen Lloyd · Oregon Health & Science University · R01 · FY2008 · ES
Mass Spectrometry of Modified RNAs
$346,201Patrick A Limbach · University Of Cincinnati · R01 · FY2023 · GM
Project 1: Tropical Plants Biological Testing
$346,172Alan Douglas Kinghorn · Ohio State University · P01 · FY2020 · CA
Mutant BRAF-regulated transcription factors in melanoma progression
$346,144Andrew E Aplin · Thomas Jefferson University · R01 · FY2019 · CA
Pathobiology of Interferon-gamma in UV radiation-induced melanomagenesis
$346,144M. Raza Zaidi · Temple Univ Of The Commonwealth · R01 · FY2019 · CA
Role of the macrophage derived XL313 epitope in angiogenesis and tumor growth
$346,144Peter C. Brooks · Mainehealth · R01 · FY2019 · CA
CD200R signaling in tumor growth, immunity and immunotherapy
$346,144Xue-Feng Bai · Ohio State University · R01 · FY2019 · CA
COMBINATION ANTIANGIOGENIC THERAPY FOR ADVANCED MELANOMA
$346,110Beth Israel Deaconess Medical Center · R21 · FY2003 · CA
Magneto-motive ultrasound imaging using molecular specific nanoparticles
$346,110Stanislav Y Emelianov · University Of Texas At Austin · R01 · FY2008 · EB
Targeted Screen for Novel Chemical Modulators of Wnt/Beta-Cat Signaling Pathway.
$346,093Ramanuj Dasgupta · New York University School Of Medicine · R01 · FY2012 · CA
Micellar Carriers for Sparingly Soluble Pharmaceuticals
$346,048Vladimir P Torchilin · Northeastern University · R01 · FY2006 · EB
Induction of Therapeutic Immunity in the Tumor Microenvironment
$346,026Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Mechanisms of photocarcinogenesis in geriatric skin
$345,960Dan F Spandau · Indiana University Indianapolis · R01 · FY2015 · ES
Design of de novo interleukin mimics for targeted immunotherapy
$345,873David Baker · University Of Washington · R01 · FY2021 · CA
Mass Spectrometry of Modified RNAs
$345,835Patrick A Limbach · University Of Cincinnati · R01 · FY2024 · GM
Induction of Therapeutic Immunity in the Tumor Microenvironment
$345,795Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP STUDIES
$345,745Case Western Reserve University · U10 · FY2000 · CA
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo
$345,713Isabelle Caroline Le Poole · Loyola University Chicago · R01 · FY2010 · AR
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
$345,579Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation
$345,510Bin Zheng · Massachusetts General Hospital · R01 · FY2015 · CA
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation
$345,510Bin Zheng · Massachusetts General Hospital · R01 · FY2016 · CA
Vesicular stomatitis VSVrp30 selectively destroys human metastatic melanoma
$345,488Anthony N Van Den Pol · Yale University · R01 · FY2016 · CA
LuIII parvovirus targets glioma
$345,488Anthony N Van Den Pol · Yale University · R01 · FY2015 · CA
Vesicular stomatitis VSVrp30 selectively destroys human metastatic melanoma
$345,488Anthony N Van Den Pol · Yale University · R01 · FY2015 · CA